Stents
Stents Market by Product Type (Coronary Stents, Esophageal Stents, Neurovascular Stents), Material (Composite Stents, Metallic Stents, Polymeric Stents), End User, Application, Technology, Patient Demographics, Type Of Coating, Stent Design - Global Forecast 2025-2030
SKU
MRR-434CCDA04EF3
Region
Global
Publication Date
February 2025
Delivery
Immediate
2024
USD 13.95 billion
2025
USD 15.01 billion
2030
USD 21.59 billion
CAGR
7.54%
360iResearch Analyst Ketan Rohom
Download a Free PDF
Get a sneak peek into the valuable insights and in-depth analysis featured in our comprehensive stents market report. Download now to stay ahead in the industry! Need more tailored information? Ketan is here to help you find exactly what you need.

The Stents Market size was estimated at USD 13.95 billion in 2024 and expected to reach USD 15.01 billion in 2025, at a CAGR 7.54% to reach USD 21.59 billion by 2030.

Stents Market
To learn more about this report, request a free PDF copy

The stent market involves medical devices used to ensure the patency of blood vessels or other tubular structures in the body. Stents are critical in a variety of healthcare applications, primarily in cardiovascular procedures, where they are inserted into narrowed or blocked arteries to maintain blood flow and prevent complications such as heart attacks. The end-use scope is broad, encompassing hospitals, cardiac centers, and outpatient facilities, where endovascular interventions are routine. Growth in the stent market is primarily influenced by the rising prevalence of cardiovascular diseases, aging populations, and technological advancements in stent design, such as the development of drug-eluting and bioresorbable stents. Economies with advanced healthcare infrastructures, like North America and Europe, dominate the market share; however, emerging economies in Asia Pacific show significant potential due to increasing healthcare investments and rising patient awareness. Challenges include stringent regulatory approvals, potential complications like in-stent restenosis, and high costs associated with advanced stents. Innovation and research are increasingly focusing on biodegradable stents, personalization of stent designs to improve patient outcomes, and integration with digital health technologies for monitoring and post-operative care. The market's nature is highly competitive, with constant innovation pushing companies to differentiate and implement value-based healthcare strategies. To capture emerging opportunities, stakeholders should invest in R&D focused on next-generation stents with enhanced safety profiles, explore partnerships for technology exchange, and target underserved regions by tailoring offerings to local healthcare needs. Moreover, addressing key limitations, such as reducing manufacturing costs and improving regulatory compliance efficiency, will be crucial for sustained market penetration. Given the continuous demand for safer and efficient cardiovascular treatments, the stent market is poised for steady growth, making it an attractive domain for strategic investments and innovation.

Ask ResearchAI anything

World's First Innovative Al for Market Research

Ask your question about the Stents market, and ResearchAI will deliver precise answers.
How ResearchAI Enhances the Value of Your Research
ResearchAI-as-a-Service
Gain reliable, real-time access to a responsible AI platform tailored to meet all your research requirements.
24/7/365 Accessibility
Receive quick answers anytime, anywhere, so you’re always informed.
Maximize Research Value
Gain credits to improve your findings, complemented by comprehensive post-sales support.
Multi Language Support
Use the platform in your preferred language for a more comfortable experience.
Stay Competitive
Use AI insights to boost decision-making and join the research revolution at no extra cost.
Time and Effort Savings
Simplify your research process by reducing the waiting time for analyst interactions in traditional methods.

Market Dynamics

The market dynamics represent an ever-changing landscape of the Stents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Expanding healthcare infrastructure in emerging economies boosting accessibility to stent treatments
    • Strategic collaborations and partnerships among market players to enhance product offerings and reach
    • Favorable reimbursement policies and insurance coverage encouraging stent adoption by healthcare providers
  • Market Restraints
    • Assessing the regulatory challenges faced by the medical stent industry affecting market dynamics
    • Understanding the market restraints that influence the stent industry and potential market shifts
    • Investigating the technical challenges and complexities involved in stent design and manufacturing
  • Market Opportunities
    • Adoption of AI and machine learning for improved diagnostic precision enhances stent application potential
    • Increased government funding for healthcare infrastructure and cardiovascular treatment advancements
    • Partnerships with biotechnology firms to develop advanced stent materials offer growth potential
  • Market Challenges
    • Scarcity of raw materials and supply chain disruptions impacting the production and delivery of stents
    • Limited differentiation among stent products driving companies to focus heavily on marketing and branding
    • Regulatory hurdles and complex approval processes affecting market entry and expansion of stents

Market Segmentation Analysis

  • Type: High global incidences of coronary diseases necessitating the deployment of coronary stents

    Coronary stents are used in procedures to open clogged heart arteries, playing a critical role in the treatment of coronary heart diseases. These stents are preferred for their minimally invasive nature and the significant improvement in patient outcomes they offer. Bare-metal stents are made of a metal alloy and act as a scaffold to keep the coronary artery open. After the stent is placed in the artery during a procedure known as angioplasty, the artery heals around the stent, maintaining the artery in an open position. Drug-eluting stents represent an advancement in stent technology. These stents are coated with a medication that is slowly released (eluted) into the artery wall to prevent scar tissue growth and, subsequently, restenosis. DES have significantly reduced the incidences of restenosis and the need for repeat interventions, making them the preferred choice in most stenting procedures. Peripheral vascular stents serve to treat peripheral artery disease (PAD), targeting arteries outside the heart and brain. They are essential in managing blood flow obstruction in limbs and preventing amputations. With an aging population and rising PAD prevalence, the demand is growing. Prostatic stents are primarily used to provide relief from urinary obstruction caused by benign prostatic hyperplasia (BPH). Their preference stems from being a less invasive alternative to surgery for patients unable or unwilling to undergo traditional procedures. Stent grafts are used in endovascular procedures to treat abdominal and thoracic aortic aneurysms. They are preferred due to their minimally invasive approach, which reduces recovery time and risk of complications compared to open surgery. Urinary stents are employed to ensure the passage of urine in cases of obstructions in the urinary tract. They are crucial in the management of kidney stones and other urological conditions. The preference for urinary stents lies in their role in preventing or treating renal failure.

  • End-User: Expansion of hospitals across the world supported by government initiatives for improving healthcare infrastructure

    Ambulatory surgical centers (ASCs) represent a critical setting for stent procedures, offering outpatient services that typically focus on elective surgeries. ASCs are characterized by their efficiency, cost-effectiveness, and the convenience they offer to patients. ASCs primarily deal with less complex coronary and peripheral interventions. The preference for lightweight, easy-to-deploy, and high-precision stents is essential in this environment to minimize operative and recovery time. This makes drug-eluting stents (DES) highly favored in ASCs for their reduced risk of restenosis. Cardiac centers are specialized facilities focused exclusively on the diagnosis and treatment of heart conditions. They are equipped to perform a diverse range of stent placements, including more complex procedures that require advanced infrastructural capabilities, such as hybrid operating rooms. There's a demand for versatile stenting options in these centers, including bioresorbable vascular scaffolds (BVS) and bio-engineered stents, to cater to a diverse range of coronary artery diseases. Capability in treating complex cases, such as bifurcation lesions or chronic total occlusions, is crucial. Hospitals represent the broadest end-user sector, encompassing a wide range of capabilities. The versatility of hospital services and their capacity to manage high-volume cases has grown in recent years. The preference in hospitals leans toward stents that offer a combination of efficacy, versatility, and cost-effectiveness. There is also a notable requirement for stents that support a broad range of vessel sizes and lesion types, accommodating the diverse patient demographic.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Stents Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

PESTLE Analysis

The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Stents Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Stents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Stents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Recent Developments

  • Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd.

    Olympus announces cutting-edge products in the stent market, offering unparalleled precision and control. Its unique design leads to faster deployment time and a structured system that guarantees optimal safety while working with this device. These stents offer remarkable performance characteristics that can provide incredible medical benefits for those undergoing procedures for numerous medical conditions. With technology advancements, Olympus is committed to helping improve patients' lives worldwide. [Published On: February 24, 2023]

  • Medtech giant Cordis acquires MedAlliance in a USD 1.1 billion deal.

    Medtech giant Cordis recently acquired Medalliance in a USD 1.1 billion deal, strengthening its grip in the stent market. The market for medical devices is rapidly growing owing to the surging demand for quality healthcare. This merger gives Cordis a significant competitive advantage in the global market and helps gain a larger share of the profits. By combining both companies' extensive expertise and resources, they will be able to meet consumer needs better and bolster their market presence. Cordis is now positioned to become a leading player in the world's stent market and is setting a high bar with this ambitious move that promises tangible results. [Published On: November 15, 2022]

  • Getinge partners with Medtronic for the manufacturing of the Radiant[TM] balloon-expandable covered stent.

    Getinge, a medical device manufacturing industry leader, recently announced a collaboration with Medtronic. Through the partnership, Getinge assisted Medtronic in producing medical stents for the global market. Through this venture, Getinge expects to offer even more comprehensive care solutions that further streamline treatments and procedures while helping bring greater precision and accuracy in diagnostics and patient recovery. Both companies are taking great strides toward advancing patient services around the world. [Published On: September 20, 2022]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Stents Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Stents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alvimedica, Andramed GmbH, Arterius Limited, B. Braun SE, Balton Sp. z o. o., Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Elixir Medical Corporation, Eurocor Tech GmbH, Integer Holdings Corporation, KYOTO MEDICAL PLANNING Co., Ltd., Lepu Medical Technology(Beijing)Co., Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Mitra Industries Pvt. Ltd., Nano Therapeutics Pvt. Ltd., QMD, REVA Medical, LLC, Rontis AG, Scitech Medical Products SA, SLTL Group, Stryker Corporation, Terumo Corporation, Veryan Medical Ltd., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Coronary Stents
    • Esophageal Stents
    • Neurovascular Stents
    • Peripheral Stents
    • Urethral Stents
  • Material
    • Composite Stents
    • Metallic Stents
      • Cobalt-Chromium
      • Nickel-Titanium
      • Stainless Steel
    • Polymeric Stents
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Application
    • Cardiac Disorders
      • Coronary Artery Disease
      • Heart Valve Disorders
    • Gastrointestinal Disorders
    • Vascular Disease
  • Technology
    • Bare Metal Stents
    • Bioresorbable Stents
    • Drug-Eluting Stents
      • Coatings
        • Polymeric Coatings
        • Reservoir-Based Coatings
  • Patient Demographics
    • Age Group
      • Adults
      • Geriatrics
      • Pediatrics
    • Gender
    • Lifestyle Choices
      • Non-Smokers
      • Smokers
  • Type Of Coating
    • Hydrophilic Coating
    • Hydrophobic Coating
    • Polymer-Based Coating
  • Stent Design
    • Closed-Cell Design
    • Hybrid Design
    • Open-Cell Design
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Stents Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Stents Market, by Product Type
  7. Stents Market, by Material
  8. Stents Market, by End User
  9. Stents Market, by Application
  10. Stents Market, by Technology
  11. Stents Market, by Patient Demographics
  12. Stents Market, by Type Of Coating
  13. Stents Market, by Stent Design
  14. Americas Stents Market
  15. Asia-Pacific Stents Market
  16. Europe, Middle East & Africa Stents Market
  17. Competitive Landscape
  18. List of Figures [Total: 33]
  19. List of Tables [Total: 639 ]
  20. List of Companies Mentioned [Total: 30]
Frequently Asked Questions
  1. How big is the Stents Market?
    Ans. The Global Stents Market size was estimated at USD 13.95 billion in 2024 and expected to reach USD 15.01 billion in 2025.
  2. What is the Stents Market growth?
    Ans. The Global Stents Market to grow USD 21.59 billion by 2030, at a CAGR of 7.54%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.